LYMPHAZURIN Side Effects

6785701-2 | Adverse Event, Blood Pressure Systolic Decreased, Heart Rate Increased
on Jun 21, 2010 Female patient from UNITED STATES , 40 years of age, weighting 169.0 lb, was treated with Lymphazurin (View Usage). Patient experienced the following unwanted or unexpected effects: adverse event, blood pressure systolic decreased, heart rate increased. Lymphazurin dosage: .

6663671-5 | Anaphylactic Shock
Patient was taking Lymphazurin (View Usage). Patient had the following side effects: anaphylactic shock on Mar 31, 2010 from UNITED STATES Additional patient health information: Female patient , 76 years of age, weighting 154.0 lb, was diagnosed with mastectomy (What is mastectomy?) and. Lymphazurin dosage: 5ml/breast Once Transmammary.

6105664-2 | Hypotension, No Therapeutic Response, Tachycardia, Urticaria
Adverse event was reported on Mar 04, 2009 by a Female patient taking Lymphazurin (View Usage) (Dosage: 0.5 Cc Injected Three Times Sc) was diagnosed with biopsy lymph gland and. Location: UNITED STATES , 65 years of age, weighting 138.9 lb, After Lymphazurin was administered, patient had the following side effects: hypotension, no therapeutic response, tachycardia, urticaria. During the same period patient was treated with ANCEF (View Ancef Review and Ancef Label ).

5959387-0 | Blood Pressure Decreased, Heart Rate Increased
on Nov 19, 2008 Male patient from UNITED STATES , 54 years of age, was diagnosed with scan with contrast and was treated with Lymphazurin (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, heart rate increased. Lymphazurin dosage: Iv X1.


5958134-6 | Circulatory Collapse
on Nov 17, 2008 Female patient from UNITED STATES , 56 years of age, weighting 202.8 lb, was diagnosed with surgery (What is surgery?) and was treated with Lymphazurin (View Usage). Patient had the following side effects: circulatory collapse. Lymphazurin dosage: 1 Cc In 9cc Of Saline Surgeon Injected Cutaneous, Operating Room Use. Patient was hospitalized.

5470540-5 | Anaphylactic Shock
Patient was taking Lymphazurin (View Usage). After Lymphazurin was administered, patient had the following side effects: anaphylactic shock on Sep 27, 2007 from UNITED STATES Additional patient health information: Male patient , 39 years of age, was diagnosed with surgery (What is surgery?) and. Lymphazurin dosage: X 1 Dose Sq. During the same period patient was treated with ANCEF (View Ancef Review and Ancef Label ), HOME HTN MEDS (View Home Htn Meds Review and Home Htn Meds Label ). Patient was hospitalized.

5247234-4 | Blood Pressure Immeasurable, Cardio-respiratory Arrest, Pco2 Increased, Peripheral Vascular Disorder, Pulse Absent
Adverse event was reported on Feb 22, 2007 by a Female patient taking Lymphazurin (View Usage) (Dosage: 3ml One Time Peri-tumor) was diagnosed with diagnostic procedure and. Location: UNITED STATES , 35 years of age, Patient experienced the following unwanted or unexpected effects: blood pressure immeasurable, cardio-respiratory arrest, pco2 increased, peripheral vascular disorder, pulse absent. During the same period patient was treated with FLAGYL (View Flagyl Review and Flagyl Label ). Patient was hospitalized.

5143114-3 | Anaphylactic Shock, Cardiac Arrest, Cardioversion, Procedural Hypotension
on Oct 31, 2006 Female patient from UNITED STATES , 71 years of age, was diagnosed with biopsy lymph gland, breast cancer (What is breast cancer?) and was treated with Lymphazurin (View Usage). Patient had the following side effects: anaphylactic shock, cardiac arrest (What is cardiac arrest?), cardioversion, procedural hypotension. Lymphazurin dosage: 2 Ml Once Id. During the same period patient was treated with MIDAZOLAM (View Midazolam Review and Midazolam Label ), ETOMIDATE (View Etomidate Review and Etomidate Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), LIDOCAINE (View Lidocaine Review and Lidocaine Label ), ROCURONIUM BROM. (View Rocuronium Brom. Review and Rocuronium Brom. Label ), SUCCINYL CHOLINE (View Succinyl Choline Review and Succinyl Choline Label ), CLARITIN (View Claritin Review and Claritin Label ).

5062635-5 | Anaphylactic Reaction, Cardiac Output Decreased
on Jul 25, 2006 Female patient from UNITED STATES , 64 years of age, weighting 179.0 lb, was diagnosed with lymphadenectomy and was treated with Lymphazurin (View Usage). After Lymphazurin was administered, patient had the following side effects: anaphylactic reaction, cardiac output decreased. Lymphazurin dosage: 5 Ml's X 1 Dose Tissue Injection. Patient was hospitalized.

4935096-1 | Bronchospasm, Skin Discolouration, Urticaria
Patient was taking Lymphazurin (View Usage). Patient experienced the following unwanted or unexpected effects: bronchospasm, skin discolouration, urticaria on Mar 03, 2006 from UNITED STATES Additional patient health information: Female patient , 68 years of age, . Lymphazurin dosage: .

4880340-2 | Orbital Oedema, Rash, Tachycardia
Adverse event was reported on Jan 11, 2006 by a Female patient taking Lymphazurin (View Usage) (Dosage: 3m Inj. In R Breast (one Time)) was diagnosed with therapeutic procedure and. Location: UNITED STATES , 67 years of age, weighting 174.2 lb, Patient had the following side effects: orbital oedema, rash (What is rash?), tachycardia. During the same period patient was treated with BUPIVACAINE (View Bupivacaine Review and Bupivacaine Label ), VALIUM (View Valium Review and Valium Label ), PERCOCET (View Percocet Review and Percocet Label ), EMLA (View Emla Review and Emla Label ), BENADRYL (View Benadryl Review and Benadryl Label ), PEPCID (View Pepcid Review and Pepcid Label ).

4848071-2 | Off Label Use, Skin Discolouration
on Dec 05, 2005 Female patient from UNITED STATES , 49 years of age, weighting 150.0 lb, was diagnosed with malignant melanoma, scan lymph nodes and was treated with Lymphazurin (View Usage). After Lymphazurin was administered, patient had the following side effects: off label use, skin discolouration. Lymphazurin dosage: About 1 Ml 1 Injection Only Id. During the same period patient was treated with TECHNETIUM COLLOID FILTERED (View Technetium Colloid -filtered- Review and Technetium Colloid -filtered- Label ).

4845943-X | Oxygen Saturation Decreased, Po2 Increased, Procedural Complication
on Dec 02, 2005 Female patient from UNITED STATES , 74 years of age, weighting 369.5 lb, was diagnosed with diagnostic procedure and was treated with Lymphazurin (View Usage). Patient experienced the following unwanted or unexpected effects: oxygen saturation decreased, po2 increased, procedural complication. Lymphazurin dosage: X1 Dose.

4840467-8 | Anaphylactic Reaction, Incision Site Haemorrhage, Myocardial Infarction, Postoperative Wound Complication, Procedural Complication
Patient was taking Lymphazurin (View Usage). Patient had the following side effects: anaphylactic reaction, incision site haemorrhage, myocardial infarction, postoperative wound complication, procedural complication on Nov 29, 2005 from UNITED STATES Additional patient health information: Female patient , weighting 249.1 lb, . Lymphazurin dosage: 5 Ml Once Other One Time Dose. Patient was hospitalized.

4809117-0 | Anaphylactic Reaction, Procedural Complication
Adverse event was reported on Oct 24, 2005 by a Female patient taking Lymphazurin (View Usage) (Dosage: 1%, Once Procedure) . Location: UNITED STATES , weighting 249.1 lb, After Lymphazurin was administered, patient had the following side effects: anaphylactic reaction, procedural complication.

4745109-8 | Blood Pressure Decreased, Blood Pressure Immeasurable, Ischaemia, Procedural Complication, Pulse Pressure Decreased
on Aug 12, 2005 Female patient from UNITED STATES , 85 years of age, weighting 116.8 lb, was treated with Lymphazurin (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, blood pressure immeasurable, ischaemia, procedural complication, pulse pressure decreased. Lymphazurin dosage: 5 Ml, X1, Inject. During the same period patient was treated with VERSED (View Versed Review and Versed Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), MORPHINE SULFATE (View Morphine Sulfate Review and Morphine Sulfate Label ). Patient was hospitalized.

4727427-2 | Reaction To Preservatives
on Jul 27, 2005 Female patient from UNITED STATES , 64 years of age, weighting 163.0 lb, was diagnosed with biopsy lymph gland and was treated with Lymphazurin (View Usage). Patient had the following side effects: reaction to preservatives. Lymphazurin dosage: 3 Ml Oto. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), TRIAMTERENE AND HYDROCHLOROTHIAZIDE (View Triamterene And Hydrochlorothiazide Review and Triamterene And Hydrochlorothiazide Label ), REQUIP (View Requip Review and Requip Label ), AMBIEN (View Ambien Review and Ambien Label ), MOBIC (View Mobic Review and Mobic Label ), HYDROCODONE BITARTRATE + ACETAMINOPHEN (View Hydrocodone Bitartrate + Acetaminophen Review and Hydrocodone Bitartrate + Acetaminophen Label ). Patient was hospitalized.

4681094-5 | Skin Discolouration, Skin Reaction
Patient was taking Lymphazurin (View Usage). After Lymphazurin was administered, patient had the following side effects: skin discolouration, skin reaction on Jun 02, 2005 from Additional patient health information: Female patient , 65 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Lymphazurin dosage: 1ml X1 Subcutaneo. Patient was hospitalized.